Oncology Institute (DFPH) Total Current Liabilities (2019 - 2026)

Oncology Institute has reported Total Current Liabilities for 8 years, with the latest figure at $79.4 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities rose 33.27% year-over-year to $79.4 million; the trailing twelve-month figure through Mar 2026 stood at $79.4 million (up 33.27% YoY), and the FY2025 full-year result was $71.0 million, up 35.9% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $79.4 million, up from $71.0 million in the prior quarter.
• The five-year high for Total Current Liabilities was $79.4 million in Q1 2026, with the low at $29.7 million in Q4 2022.
• Historically, Total Current Liabilities has averaged $45.9 million across 5 years, with a median of $36.1 million in 2022.
• Annual changes were most pronounced in 2022 — Total Current Liabilities soared 18271.88% — and 2023, when it slipped 7.26%.
• Oncology Institute's Total Current Liabilities stood at $29.7 million in 2022, then advanced by 17.05% to $34.8 million in 2023, then jumped by 50.09% to $52.2 million in 2024, then surged by 35.9% to $71.0 million in 2025, then advanced by 11.82% to $79.4 million in 2026.
• The last three Total Current Liabilities figures came in at $79.4 million (Q1 2026), $71.0 million (Q4 2025), and $65.6 million (Q3 2025), per Business Quant data.